Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Peptide news, guides, and explainers

News, guides, and explainers that feed the reference pages rather than replace them. Each post cites its sources and links to the canonical peptide, condition, comparison, or legal page for the full record.

66 posts. RSS feed. Posts marked draft are pending editorial review.

  1. Explainer9 min read

    BPC-157 and cancer: what the evidence shows

    Does BPC-157 cause cancer or feed tumors? The concern is theoretical, based on blood vessel growth in animal studies. No human study has assessed it, and FDA found no carcinogenicity data.

    • BPC-157
    • cancer
    • safety
    • side effects
    • angiogenesis
    • FDA
  2. Explainer9 min read

    GLOW peptide before and after: what the evidence shows

    No study has measured GLOW peptide before and after results. What each ingredient's human evidence shows for skin and hair, documented side effects, and the blend's legal status.

    • GLOW
    • before and after
    • side effects
    • benefits
    • GHK-Cu
    • BPC-157
    • TB-500
    • blends
  3. Sponsored

    CJC-1295 / Ipamorelin

    from Bodybuilding Peptides

    Partner lists from $220/month

    See prescription options

    We may earn a commission from these links.

    Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.

  4. Q&A9 min read

    Ipamorelin side effects and benefits: what studies show

    Ipamorelin side effects in its one human trial matched placebo, but FDA flags serious events with IV use. Claimed benefits for muscle, fat loss, and sleep are untested. Not FDA approved.

    • ipamorelin
    • side effects
    • benefits
    • safety
    • growth hormone
    • compounding
  5. Explainer10 min read

    MOTS-c side effects and benefits: what the evidence shows

    No published human study has reported MOTS-c side effects, because none has given it to people and posted results. The mouse benefit claims, the safety gaps FDA named, and its legal status.

    • MOTS-c
    • side effects
    • safety
    • benefits
    • evidence grades
  6. Guide7 min read

    Switching from tirzepatide to retatrutide: what's possible

    Retatrutide is not approved, so there is no prescription switch from tirzepatide. What trial eligibility says about prior GLP-1 use, how the drugs differ, and what to do instead.

    • GLP-1
    • retatrutide
    • tirzepatide
    • clinical trials
    • access
    • legal
  7. Q&A9 min read

    TB-500 side effects and benefits: what the evidence shows

    No human study of TB-500 has been published, so its side effects in people are unknown. What FDA's 2026 review found, which studies tested a different peptide, and its legal status.

    • TB-500
    • side effects
    • safety
    • benefits
    • thymosin beta-4
    • evidence grades
  8. Explainer10 min read

    Tesamorelin side effects: what the FDA label and trials show

    Tesamorelin side effects from the Egrifta label and phase 3 trials: injection site reactions, joint pain, swelling, glucose and IGF-1 effects, allergic reactions, and who should not use it.

    • tesamorelin
    • Egrifta
    • side effects
    • safety
    • IGF-1
    • growth hormone
  9. Study breakdown11 min read

    Thymosin alpha-1 benefits and side effects: the evidence

    What randomized trials of thymosin alpha-1 showed in hepatitis B, sepsis, COVID-19, and vaccine response, which side effects they recorded, and where wellness claims outrun the data.

    • thymosin alpha-1
    • thymalfasin
    • Zadaxin
    • benefits
    • side effects
    • human studies
    • immune
  10. Q&A8 min read

    CJC-1295 side effects, alone and with ipamorelin

    CJC-1295 side effects in small human trials included injection site reactions, headache, flushing, and a faster heart rate. The ipamorelin blend is untested. Neither peptide is FDA approved.

    • CJC-1295
    • side effects
    • safety
    • growth hormone
    • IGF-1
    • ipamorelin
    • compounding
  11. Sponsored

    Tesamorelin / Ipamorelin

    from Bodybuilding Peptides

    Partner lists from $274/month

    See prescription options
  12. Explainer5 min read

    Sermorelin vs HGH: mechanism, evidence, and legal status

    Sermorelin signals the pituitary to release growth hormone; HGH (somatropin) is the hormone itself. Only somatropin is FDA approved today, and anti-aging use of either is off-label.

    • sermorelin
    • HGH
    • somatropin
    • growth hormone
    • anti-aging
    • comparison
  13. Explainer5 min read

    Tesamorelin vs HGH: how they differ and which is approved

    Tesamorelin (Egrifta) signals the pituitary to release growth hormone and is approved for HIV-associated belly fat; HGH (somatropin) is the hormone itself, approved for other conditions.

    • tesamorelin
    • Egrifta
    • HGH
    • somatropin
    • growth hormone
    • comparison
  14. Explainer8 min read

    Are peptide injections safe? What is known and unknown

    FDA-approved peptide injections have documented side effects on their labels. Compounded and research-only peptides add unknowns: sterility, identity, dose accuracy, and contamination.

    • peptide therapy
    • safety
    • side effects
    • compounding
    • research peptides
    • adverse events
  15. Explainer7 min read

    Minoxidil side effects: topical, oral, shedding, and pets

    Minoxidil side effects differ by form: scalp irritation and unwanted facial hair with topical use, body hair and fluid retention with oral use. Plus shedding, pregnancy, and the danger to cats.

    • minoxidil
    • side effects
    • hair loss
    • oral minoxidil
    • pregnancy
    • pet safety
  16. Explainer7 min read

    Oral minoxidil for hair loss: evidence and side effects

    Low-dose oral minoxidil is an off-label hair loss treatment. What the FDA label for the blood pressure tablet says, what the hair loss trials found, and the side effects they reported.

    • minoxidil
    • oral minoxidil
    • hair loss
    • hair growth
    • androgenetic alopecia
    • side effects
  17. Explainer7 min read

    Sildenafil vs Viagra: same drug, generic vs brand

    Sildenafil is the active ingredient in Viagra. How generic sildenafil compares, why 20 mg tablets are labeled for pulmonary hypertension, the label side effects, and the nitrate contraindication.

    • sildenafil
    • Viagra
    • Revatio
    • erectile dysfunction
    • side effects
    • generic drugs
  18. Explainer7 min read

    5-amino-1MQ for fat loss: mouse data, no human trials

    5-amino-1MQ reduced fat mass in obese mice, but no human study of any kind has been published. What the mouse studies found, capsules vs injection, side effects, and legal status.

    • 5-amino-1MQ
    • NNMT
    • fat loss
    • weight loss
    • evidence grades
  19. Study breakdown6 min read

    BPC-157 human studies: every published report and registered clinical trial

    Every published BPC-157 human report, with sample size and limits, plus every registered clinical trial on ClinicalTrials.gov. About 30 people, no control groups, and no randomized results yet.

    • BPC-157
    • human studies
    • clinical trials
    • evidence grades
    • research
  20. Explainer6 min read

    BPC-157 nasal spray: what is and is not known about intranasal use

    No published study has given BPC-157 as a nasal spray to animals or people. What the one nose-related rat study tested, what a nasal peptide must prove, and its legal status.

    • BPC-157
    • nasal spray
    • intranasal
    • routes
    • evidence grades
  21. Guide7 min read

    Compounded tirzepatide in 2026: legality, cost, and safety

    The tirzepatide shortage ended in December 2024 and routine compounded copies ended in 2025. What is still lawful, what it cost, FDA safety warnings, and how to check a pharmacy.

    • GLP-1
    • tirzepatide
    • compounding
    • cost
    • regulatory
    • safety
  22. Explainer6 min read

    Copper peptides for hair: what the studies show

    Does GHK-Cu help with hair growth? Copper peptides enlarge hair follicles in lab and mouse studies, but no randomized trial of GHK-Cu alone for hair loss exists. How they compare with minoxidil.

    • GHK-Cu
    • copper peptide
    • hair loss
    • hair growth
    • minoxidil
    • finasteride
  23. Explainer6 min read

    Do GLP-1 patches work? What they contain and what the evidence says

    No FDA-approved GLP-1 patch exists. Here is why GLP-1 drugs cannot pass through skin from a sticker, what patch ingredients have been tested by mouth, and how to read patch reviews.

    • GLP-1
    • patches
    • supplements
    • weight loss
    • consumer protection
  24. Q&A7 min read

    Does tesamorelin build muscle? What the trials show

    Tesamorelin raised lean body mass about 1.2 kg in HIV trials and slightly increased trunk muscle area, but no trial tested strength or muscle growth, and it is prohibited in sport.

    • tesamorelin
    • Egrifta
    • muscle growth
    • lean mass
    • body composition
    • growth hormone
  25. Study breakdown11 min read

    Epitalon human studies: what the small cohorts actually measured

    Most epitalon human data come from one group and used the pineal extract Epithalamin, not synthetic epitalon. What each study measured, the claimed benefits versus the evidence, and side effects.

    • epitalon
    • epithalon
    • longevity
    • telomerase
    • melatonin
    • human studies
  26. Explainer6 min read

    GLP-1 supplements vs GLP-1 drugs: what GLP-1 boosters actually do

    Berberine, fiber, and probiotics sold as GLP-1 boosters are not GLP-1 drugs. Here is the human evidence for each ingredient, graded, and how it compares with semaglutide and tirzepatide.

    • GLP-1
    • supplements
    • berberine
    • weight loss
    • evidence grades
  27. Guide10 min read

    How to get peptides prescribed legally in 2026

    Which peptides a licensed prescriber can lawfully write for today, which are neither approved nor 503A eligible, how telehealth rules work, and the red flags that mean a product is not a prescription.

    • peptide therapy
    • access
    • telehealth
    • compounding
    • legal
  28. Guide6 min read

    How to get retatrutide: clinical trials, expanded access, and the law

    Retatrutide is not approved, so a clinical trial or FDA expanded access is the only lawful route. How to search ClinicalTrials.gov, how both work, and why online and compounded sources are unlawful.

    • GLP-1
    • retatrutide
    • access
    • clinical trials
    • legal
    • obesity
  29. Explainer8 min read

    Klow vs Glow peptide: what KPV adds and what is known

    Klow is the Glow blend (GHK-Cu, BPC-157, TB-500) plus KPV. Each ingredient compared, what KPV is claimed to add, how both relate to the Wolverine stack, and why no study tests either blend.

    • Klow
    • Glow
    • KPV
    • GHK-Cu
    • BPC-157
    • TB-500
    • blends
  30. Explainer6 min read

    Melanotan 1 before and after: what the afamelanotide trials measured

    Melanotan 1 is afamelanotide, approved only as an implant for a rare light sensitivity disease. What the tanning and approval trials measured, what happens to moles, and why tanning use is unapproved.

    • melanotan I
    • afamelanotide
    • tanning
    • erythropoietic protoporphyria
    • safety
    • regulatory
  31. Explainer6 min read

    Melanotan 2 before and after: what trials and case reports show

    Melanotan 2 before and after photos show a tan. Early trials measured it in a few men; case reports since document new moles, melanoma, priapism and FDA safety concerns.

    • melanotan II
    • MT2
    • tanning
    • skin cancer
    • safety
    • regulatory
  32. Explainer7 min read

    Microdosing GLP-1s and tirzepatide: what the evidence says

    No trial has tested microdosing semaglutide or tirzepatide. What the labels say about dose steps and why they exist, FDA's dosing-error warnings, and what to ask a prescriber.

    • GLP-1
    • microdosing
    • tirzepatide
    • semaglutide
    • safety
    • compounding
  33. Explainer7 min read

    MOTS-c for weight loss: what mouse and human studies show

    MOTS-c prevented diet-induced obesity in mice, but no human trial has tested it for weight loss. What the mouse data show, what human blood studies found, and where it stands legally.

    • MOTS-c
    • weight loss
    • fat loss
    • metabolism
    • evidence grades
  34. Explainer6 min read

    N-acetyl semax and selank amidate: is there any human data?

    What N-terminal acetylation and C-terminal amidation are claimed to change in semax and selank, what the lab studies actually found, and why no human study has tested either modified version.

    • semax
    • selank
    • peptide chemistry
    • nasal spray
    • evidence
    • regulatory
  35. Explainer8 min read

    Peptide before and after: trial results vs marketing photos

    Measured peptide before and after results: GLP-1 weight change, tesamorelin visceral fat, and regain after stopping, compared with Glow, GHK-Cu, BPC-157, and Wolverine claims.

    • before and after
    • results
    • GLP-1
    • tesamorelin
    • GHK-Cu
    • BPC-157
    • Glow
    • Wolverine stack
  36. Ranked by evidence9 min read

    Peptide stacks: what each common component has shown alone

    No trial has tested a multi-peptide stack for muscle growth or fat loss. Nine common stack components ranked by their own human evidence, legal status, and WADA status. No protocols.

    • peptide stack
    • muscle growth
    • fat loss
    • body composition
    • evidence grades
    • WADA
  37. Ranked by evidence8 min read

    Peptides for men, ranked by human evidence

    hCG, GLP-1 drugs, teriparatide, and tesamorelin have human trials and a lawful route. PT-141 is off-label in men; kisspeptin and melanotan II have no approval or 503A listing. Ranking, legality, WADA.

    • men
    • hypogonadism
    • erectile dysfunction
    • body composition
    • evidence grades
    • WADA
  38. Ranked by evidence10 min read

    Peptides for muscle growth, ranked by human evidence

    MK-677, sermorelin, tesamorelin, CJC-1295, IGF-1 LR3, and more ranked by human evidence. None is approved for muscle growth, and all ten are banned in tested sport.

    • muscle growth
    • body composition
    • recovery
    • evidence grades
    • WADA
    • growth hormone
  39. Ranked by evidence10 min read

    Peptides for weight loss, ranked by human evidence

    Tirzepatide, semaglutide, and liraglutide lead on human trials. Retatrutide is trial-only, and AOD-9604 and 5-amino-1MQ are animal-only. Ranking, legal status, and dated prices.

    • weight loss
    • obesity
    • GLP-1
    • evidence grades
    • tirzepatide
    • semaglutide
    • retatrutide
  40. Ranked by evidence8 min read

    Peptides for women, ranked by human evidence

    GLP-1 drugs, teriparatide, abaloparatide, and Vyleesi (PT-141) have real trials in women. Kisspeptin is research-only and GHK-Cu rests on small skin studies. The ranking and legal status.

    • women
    • osteoporosis
    • sexual health
    • weight loss
    • evidence grades
    • PT-141
  41. Explainer7 min read

    Retatrutide side effects: what the trials reported, dose by dose

    Nausea, diarrhea, dysesthesia, heart rate, and dropouts in the retatrutide trials, with placebo rates. What the data say about safety, and what is still unknown.

    • GLP-1
    • retatrutide
    • side effects
    • safety
    • trials
    • obesity
  42. Explainer7 min read

    Selank nasal spray: the evidence, and combining it with semax

    What the intranasal selank studies measured, whether the route matters, and what is known about semax and selank nasal spray together: no trial has tested the combination.

    • selank
    • semax
    • nasal spray
    • anxiety
    • combinations
    • regulatory
  43. Q&A6 min read

    Selank withdrawal: dependence, benzodiazepines, and alcohol

    Does selank cause withdrawal? What studies measured on dependence, how it compares with benzodiazepines, the rodent alcohol and opioid withdrawal studies, and the untested alcohol interaction.

    • selank
    • withdrawal
    • benzodiazepines
    • alcohol
    • anxiety
    • safety
  44. Explainer8 min read

    Semax nasal spray: what the intranasal studies show

    Semax was developed in Russia as nasal drops. What the intranasal stroke and imaging studies measured, how nasal and injected data compare, and what the July 2026 PCAC meeting means.

    • semax
    • nasal spray
    • cognitive
    • stroke
    • PCAC
    • regulatory
  45. Explainer7 min read

    TB-500 vs thymosin beta-4: is it the same peptide?

    FDA says TB-500 and thymosin beta-4 are not the same substance. What each one is, which one the human and animal studies used, capsules and sprays, and the cancer question.

    • TB-500
    • thymosin beta-4
    • TB4
    • healing
    • evidence grades
  46. Explainer8 min read

    Tesamorelin before and after: what the trials measured

    Tesamorelin results from the 26 and 52 week trials: about 15 to 18% less visceral fat, little change in weight, and fat that came back after stopping. Why photos are not trial data.

    • tesamorelin
    • Egrifta
    • visceral fat
    • results
    • before and after
    • HIV lipodystrophy
  47. Guide7 min read

    Tesamorelin prescription: who qualifies and how to get one

    How to get tesamorelin legally: who qualifies for Egrifta WR on label, how off-label prescribing works, why compounded tesamorelin is not lawful, what a visit should check, and cost.

    • tesamorelin
    • Egrifta
    • prescription
    • telehealth
    • compounding
    • access
  48. Explainer7 min read

    Tesamorelin vs sermorelin vs ipamorelin: evidence and legality

    Tesamorelin, sermorelin, and ipamorelin compared in one table: mechanism, FDA approval, compounding status, human evidence, and WADA status, with links to each pairwise comparison.

    • tesamorelin
    • sermorelin
    • ipamorelin
    • growth hormone
    • comparison
    • compounding
  49. Guide6 min read

    Thymosin alpha-1 access: approved abroad, not in the US

    Thymosin alpha-1 is approved as Zadaxin in more than 30 countries but has never been FDA approved, and it is not on the 503A bulks list. What that means for access, forms, and thymalin.

    • thymosin alpha-1
    • thymalfasin
    • Zadaxin
    • access
    • legal status
    • immune
  50. Explainer7 min read

    Topical vs injectable GHK-Cu: what the evidence shows

    Topical GHK-Cu has small skin studies and is a lawful cosmetic. Injectable GHK-Cu has no human trial and is not on the 503A bulks list. Evidence, absorption, safety, and legality compared.

    • GHK-Cu
    • copper peptide
    • topical
    • injection
    • skin aging
  51. Explainer10 min read

    What is peptide therapy? What clinics sell, what is legal, and what works

    Peptide therapy means three different things: FDA-approved drugs, compounded prescriptions, and research-only products. Here is how to tell them apart, what the evidence shows, and what it costs.

    • peptide therapy
    • access
    • compounding
    • regulatory
    • evidence grades
  52. Guide9 min read

    Can you get a GLP-1 through telehealth in your state?

    Yes in every state, but the rules for the visit, the prescriber's license, and the pharmacy differ. How state telehealth law shapes GLP-1 access, with state examples.

    • GLP-1
    • telehealth
    • access
    • state law
    • semaglutide
    • tirzepatide
  53. Ranked by evidence4 min read

    GLP-1 side effects ranked by trial frequency

    Nausea tops the list, but the label warnings matter more. Side effects of semaglutide and tirzepatide ranked by how often they occurred in the trials, with placebo rates for context.

    • GLP-1
    • semaglutide
    • tirzepatide
    • retatrutide
    • side effects
    • safety
  54. Guide5 min read

    How to get a compounded GLP-1 prescription in 2026

    Compounded semaglutide and tirzepatide are now limited to documented patient-specific needs. Here is how the lawful path works, how to check a pharmacy, and what the branded alternatives cost.

    • GLP-1
    • semaglutide
    • tirzepatide
    • compounding
    • access
    • telehealth
  55. Explainer5 min read

    How to read a peptide study

    A practical checklist for judging peptide research: who was studied, how it was designed, what was measured, and whether it was replicated. Worked through with real studies.

    • evidence
    • research literacy
    • methodology
  56. Ranked by evidence6 min read

    Peptides for tendon recovery, ranked by human evidence

    BPC-157, TB-500, GHK-Cu, PEG-MGF, and IGF-1 LR3 ranked by our evidence grades. None has a published human tendon trial. Here is the ranking, the reasoning, and what does have human data.

    • tendon
    • injury
    • healing
    • evidence grades
    • BPC-157
    • TB-500
  57. Explainer5 min read

    Retatrutide FDA approval status in 2026: phase 3 results and filing

    Retatrutide is not FDA approved. Eli Lilly says its phase 3 data support FDA submissions. Where the five readouts stand, what FDA review involves, and why no one can lawfully sell it today.

    • GLP-1
    • retatrutide
    • triple agonist
    • trials
    • regulatory
    • obesity
  58. Study breakdown4 min read

    SURMOUNT-5 explained: tirzepatide vs semaglutide head to head

    The first head-to-head obesity trial of tirzepatide and semaglutide found a 20.2% vs 13.7% weight loss gap at 72 weeks. What it tested, what it did not, and what it means for access.

    • GLP-1
    • tirzepatide
    • semaglutide
    • obesity
    • trials
    • head to head
  59. Q&A4 min read

    Wegovy pill vs injection: what the trials show

    Semaglutide now comes as a daily tablet and a weekly injection for weight management. We compare the trials, the label differences, and what each costs to get.

    • GLP-1
    • semaglutide
    • oral
    • obesity
    • trials
    • access
  60. Explainer6 min read

    What are peptides? A plain-English guide

    Peptides are short chains of amino acids. Some are FDA approved medicines, some are compounded, and many are unapproved research chemicals. Here is how to tell them apart.

    • basics
    • peptides
    • regulation
    • evidence
  61. Trends and data5 min read

    What happened to compounded semaglutide

    Compounded semaglutide went from a shortage workaround to a narrow, patient-specific exception. Here is the timeline, what FDA found, and what access looks like in 2026.

    • GLP-1
    • semaglutide
    • tirzepatide
    • compounding
    • regulatory
    • cost

Educational reference, not medical advice. Read the full disclaimer and talk to a licensed provider before starting, stopping, or combining any treatment.